
<DOC>
<DOCNO>WT03-B24-195</DOCNO>
<DOCOLDNO>IA064-000378-B005-210</DOCOLDNO>
<DOCHDR>
http://www.sosei.com:80/Companies/onyxjp.html 206.86.52.80 19970112100055 text/html 9094
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 10:00:57 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 8912
Last-modified: Sun, 12 May 1996 19:30:18 GMT
</DOCHDR>
<HTML><HEAD><TITLE>ONYX Pharmaceuticals</TITLE></HEAD><BODY BGCOLOR=#FFFFFF>
<IMG Align=Middle SRC="../Graphics/onyx.gif">
<H1>ONYX ƒtƒ@?[ƒ}ƒX?[ƒ`ƒJƒ‹ƒY</H1><H3>Corporate Profile</H3>
<A HREF = "onyx.html"><IMG  Align=Middle SRC="../Graphics/english_button.gif"></A> <A HREF = "onyx.html">“ϊ–{•¶</A>
<HR>

ONYX Pharmaceuticals<BR>
3031 Research Drive<BR>
Richmond, CA 94806<BR>
510-262-8772<BR>
510-222-9758 (fax)<P>

<B>‰οΠ‚Μ–πυ?F</B><BR>
Hollings C. Renton<BR>
Π’·?ACEO<P>

Dr. Frank McCormick<BR>
‰Θw’S“–?Σ”C<P>

Dr. William Gerber<BR>
‹Ζ–±’S“–?Σ”C<P>

<B>Πυ?F</B>
35?l‚Μ”m‚¨‚ζ‚Ργw”m‚πά‚ί?A85?l‚Ε‚·?B<P>

<B>{?έ?F</B>

ONYX PharmaceuticalsΠ‚Ν?AƒJƒƒtƒHƒ‹ƒjƒA?B?Aƒƒbƒ`ƒ‚ƒ“ƒhs‚ΙΚ’u‚µ‚Δ‚¨‚θ?A
40,000•½•ϋƒtƒB?[ƒg‚Μ{?έ‚Ε‚·?B<P>

<B>‘n‹Ζ?F</B> <BR>

ONYX‚Ν?ARasƒIƒ“ƒRƒWƒ“‚Μ•–μ‚Ι‚¨‚―‚ιFrank McCormick, Ph.D.‚π‚Ν‚¶‚ί?A”ή‚Μ¤‹†Ί?A‚»‚µ‚Δξα‡?A—}³β“`q‚¨‚ζ‚Ρ?M?†•Ο·‚Μ•–μ‚Ε‚Μ‘n?έ‚Ιg‚ν‚Α‚½‰Θw?κ–ε‚ΜΪ–β‚Ι‚ζ‚ι—D?G‚Θ¤‹†‚Ιξ‚Γ‚Ά‚Δ?Aƒ`ƒ?ƒ“?EƒR?[ƒ|ƒ?[ƒVƒ‡ƒ“‚©‚ηƒXƒsƒ“?EƒIƒt‚µ‚½‰οΠ‚Ε‚·?B<P>

<B>‘n—§“ϊ?F</B>
1992”N424“ϊ<P>

<B>“‘z:</B>  ($000) <P>


<CENTER>	<table border=4>
<tr><th align=center>ƒVƒ…?[ƒY A <th align=center>	ƒVƒ…?[ƒY B	<th align=center>ƒVƒ…?[ƒY C	<th align=center>ƒVƒ…?[ƒY D	<th align=center>?«—‚Μ‘–{ <tr>
<td align=center>	400	<td align=center>	5,000	<td align=center>	12,200	<td align=center>	17,100	<td align=center>	7,333
</table><P></CENTER>

<B>ε—v‚Θ“‘?F</B><BR>
Chiron, Bayer ‚¨‚ζ‚Ρ Parke-Davis‚Μ‘Ό‚Ι?AAvalon Ventures, Institutional Venture Partners, Kleiner Perkins Caufield & Byers, Sprout Group, Sierra Ventures, Robertson, Stephens & Co., Sequoia Capital, New York Life, Mutual of New York, Alex Brown, Forward Ventures‚πά‚ί?A—DΚ‚Μƒxƒ“ƒ`ƒƒ?[?EƒLƒƒƒsƒ^ƒ‹“‘‚‘µ‚Α‚Δ‚Ά‚ά‚·?B<P>

<B>?ΰ–±”wi?F</B><BR>
ONYX ‚Ν?A–―Τ‰οΠ‚Ε‚ ‚θ?A»?έ‚ά‚Ε4?η2•S–ƒhƒ‹‚Μ”®”­?s‚Ι‚ζ‚Α‚Δ‘–{’²’B‚π‚µ‚Δ‚«‚ά‚µ‚½?B<P>

<B>‰οΠT—v?F</B><BR>
ONYX ‚Μ”C–±‚Ν?A?d‚Ά•a‹C‚π΅—Γ‚·‚ι?V‹K–ς•i‚πJ”­‚·‚ι‚±‚Ζ‚Ε‚·?B¤‹†‚Μ’†?S‚Ζ‚Θ‚ι“®‚Ν?A?V‹K΅—Γ–@‚πJ”­‚·‚ι‚½‚ί?A?Ε?V‚Μ•q?¶•¨w‹Z?p‚Ζ?Ag‘ε‚µ‚Δ‚Ά‚ι?Χ–E“ΰ‚Μ?M?†‰ρH‚Ι‚Β‚Ά‚Δ‚Μ’m―‚π‹‚Ρ•t‚―‚ι‚±‚Ζ‚Ε‚·?B¤‹†‚¨‚ζ‚Ρ–ς•i‚Μ?V‹KJ”­‚π?d“_“I‚Ιp‘±‚µ‚Θ‚‚η?A—Υ?°J”­‚β?»•i‰»‚Μ‚½‚ί‚Μι‹Ζƒp?[ƒgƒi?[‚π‹?‚ί‚ι‚Μ‚–‹Ζ‚Μ‘_‚Ά‚Ε‚·?B<P>

<B>’ρg?F</B><P>
<CENTER><TABLE BORDER =4>
<TR><TH align=center>‰οΠ–Ό	<TH align=center>		•–μ		<TH align=center>		“ϊ•t<TR>
<TD align=center>Bayer		<TD align=center>		Ras	<TD align=center>			1994”N5<TR>
<TD align=center> Parke-Davis	<TD align=center>	?Χ–EƒTƒCƒNƒ‹’²?ί <TD align=center>1994”N5<TR>
<TD align=center> Eli Lilly	<TD align=center>		“ϋΰ<TD align=center>	1994”N5</TABLE><P></CENTER>

<B>‹Z?pT—?F</B><P>
ONYX‚Ν?A’Zϊ“I‚Ι•qξα‡w‚Ι?Ε“_‚π?‡‚ν‚Ή?AO‚Β‚Μ?V‹K–ς•iJ”­ƒvƒ?ƒOƒ‰ƒ€‚π?έ‚―‚Δ‚Ά‚ά‚·?B<P>

<EM>Ras?M?†?F</EM><BR> 
ONYX‚Μ?Ε?‰‚Μ–ς•i?V‹KJ”­‚Μƒvƒ?ƒOƒ‰ƒ€‚Ν?ARas?M?†‰ρH‚πƒe?[ƒ}‚Ι‚µ‚½‚ΰ‚Μ‚Ε?A?΅‚Ν?AONYX/Bayer‚Μ‹¤“―J”­‚Ι‚ζ‚Α‚Δ?i‚ί‚η‚κ‚Δ‚Ά‚ά‚·?BRas‚Ζ‚Ά‚¤‚Μ‚Ν?A?¬’·ƒtƒ@ƒNƒ^?[‚Μ?«‰»‚π‹N‚·’`”’Ώ‚Ε?A?Χ–E?¬’·‚Ζ‘α‚π?§ΐ‚·‚ι–π„‚π‰Κ‚½‚·‚ΰ‚Μ‚Ε‚·?BRas‚Μ“®‚«‚π~‚ί‚ι?A‚ ‚ι‚Ά‚Ν?A?³?ν‚Μƒƒxƒ‹‚Ι—}‚¦‚ι?¬•q–ς•i‚Ν?Aΰ‚Ι‘Ξ‚µ‚Δ—Lψ“I‚Θ?V‚µ‚Ά΅—Γ‚Ι‚Θ‚ι‰Β”\?«‚π?‚Β‘Ό‚Ι?AƒƒEƒ}ƒ`Φ?ί‰‚β£‚Ή‚ρ‚Θ‚Η‚Μ‰ί‘??B•a‚Ι‚ΰψ‰Κ‚‚ ‚ι‚Ζ©‚η‚κ‚Δ‚Ά‚ά‚·?B<P>

<EM>?Χ–EƒTƒCƒNƒ‹‚ΜƒƒMƒ…ƒ?[ƒ^?[?F</EM><BR>
ONYX‚Μ¤‹†‚Ν?A?Χ–E‚ΜƒTƒCƒNƒ‹‚π’²?ί‚·‚ι’`”’Ώ‚Ι‚ΰ?Ε“_‚π“–‚Δ‚Δ‚Ά‚ά‚·?BONYX‚Ζι‹Ζƒp?[ƒgƒi?[‚ΕWarner-Lambert‚Μ–‹Ζ•”‚Μκ‚Β‚Ε‚ ‚ιParke-Davis‚Ν?Aΰ‚β‚»‚Μ‘Ό‚Μ•a‹C‚Μ?V‚µ‚Ά΅—Γ‚πJ”­‚·‚ι‚±‚Ζ‚π–Ϊw‚µ‚Δ‚Ά‚ά‚·?B?»•i‰»‰Β”\‚Μ–ς•i‚Ν?A“Λ‘R•ΟΩ‚π‹N‚µ‚½?Χ–EƒTƒCƒNƒ‹‚Μ’`”’Ώ‚Μ‹@”\‚π?³?ν‚Ι‰ρ•‚³‚Ή‚ι“­‚«‚π‚·‚ι‚©?A‚ ‚ι‚Ά‚ΝΩ?ν?Χ–E‚Μ?¬’·?^€–SƒTƒCƒNƒ‹‚π?³?ν‚Ι‰ρ•‚³‚Ή‚ι“­‚«‚π‚·‚ι‚Ε‚ ‚λ‚¤‚Ζ©‚η‚κ‚Δ‚Ά‚ά‚·?B
<P>

<EM>p53“Λ‘R•ΟΩξα‡‚ΜƒAƒfƒmƒEƒCƒ‹ƒX΅—Γ?F</EM><BR>
ONYX‚Ε‚Ν?AƒAƒfƒmƒEƒCƒ‹ƒX‚π‘I‘π“I‚Ι?Δ»‚µ•Ο‰»‚³‚Ή‚ι‚Ζ?A?³?ν‚Μ?Χ–E‚π‚»‚Μ‚ά‚ά‚Ι‚µ‚Δp53•s‘«‚Μξα‡?Χ–E‚πE‚·‚Ζ‚Ά‚¤?d—v‚Θ”­©‚π‚µ‚ά‚µ‚½?B±Η“ΰ‚Θ‚η‚Ρ‚Ι?¶‘Μ“ΰ‚Μΐ±‚Ι‚ζ‚θ‚±‚ΜƒRƒ“ƒZƒvƒg‚πΐ?Ψ‚µ?A‚±‚Μ?»•i‰»‚·‚ι–ς•i‚1996”N‚Μ‚Ν‚¶‚ί‚Ι—Υ?°ΐ±‚Ι“ό‚ι—\’θ‚Ε‚·?B ‚ά‚½?A‚±‚Μ”­©‚π‘Ό‚ΜƒEƒCƒ‹ƒX‚β•a‹C‚Ι‚ΰ“WJ‚µ‚Δ‚Ά‚ά‚·?B<P>

<B>»?έ‚Μι‹Ζƒp?[ƒgƒi?[?F</B>
<UL><LI> Bayer
<LI> Parke-Davis
<LI> Eli Lilly
</UL>

<B>ι‹Ζƒp?[ƒgƒi?[ΦW?¬—§‚Μ‹@‰ο?F</B><BR>
ONYX ‚Ν?Ae–ς•iƒvƒ?ƒOƒ‰ƒ€‚Ι‚Β‚Ά‚Δ‚Μι‹Ζ“―–Ώ‚π?¬—§‚µ‚Δ‚Ά‚­?ν—‚πp‘±‚·‚ι‚Β‚ΰ‚θ‚Ε‚·?B p53“Λ‘R•ΟΩξα‡‚ΜƒAƒfƒmƒEƒCƒ‹ƒX΅—Γ‚Μ•–μ‚Ε‚±‚¤‚Ά‚Α‚½“―–Ώ‚π1996”N‚Ι’χ‹‚Ε‚«‚ι‚±‚Ζ‚πϊ‘‚µ‚Δ‚Ά‚ά‚·?B‚ά‚½?A Warner-Lambert‚Ζ‹¤‚Ι?Χ–EƒTƒCƒNƒ‹‚Μ‹¤“―¤‹†‚π‘Ξ?Ϋ‚Ζ‚µ‚½“ϊ–{ι‹Ζ‚Μƒp?[ƒgƒi?[‚π’T‚µ‚Δ‚Ά‚ά‚·?B<P>

<B>o‰c?F</B><BR>
Dr. Frank McCormick - <a href=mailto:frank@ONYX-pharm.com>frank@ONYX-pharm.com</a><BR>
Dr. Frank McCormick ‚Ν?A•qΦW‚ΕONYX‚ε‚Ιζ‚θ?γ‚°‚Δ‚Ά‚ιRas ƒIƒ“ƒRƒMƒ“‚ΖGAP’`”’Ώ‚Μ¤‹†‚Ε’m–Ό“x‚Μ?‚‚Άw“±‚Ε‚·?BONYX‘n‹ΖΘ‘O?A Dr. Frank McCormick ‚Ν?AChiron Corporation‚Μ΅—Γ?E?¶•¨w¤‹†’S“–‚Μ•›Π’·‚Ε‚µ‚½?Bo—π‚π‚³‚©‚Μ‚Ϊ‚ι‚Ζ?A ‚ά‚Έ1981”N‚Ι Cetus Corporation‚Ζ‚Ά‚¤‰οΠ‚Μ‰ΘwƒXƒ^ƒbƒt‚Ζ‚µ‚Δ“όΠ‚µ?A1990”N‚Ι?A?V‹K¤‹†“®’S“–‚Μ•›Π’·‚ά‚Ε•q?¶•¨w’S“–‚ΜƒfƒCƒƒNƒ^?[‚π‹Ξ‚ί‚Δ‚Ά‚ά‚µ‚½?B  ƒXƒgƒj?[?Eƒuƒ‹ƒbƒNs‚Μƒjƒ…?[ƒ?[ƒN?B—§‘εw‚Θ‚η‚Ρ‚Ιƒ?ƒ“ƒhƒ“‚Μ’ι?‘ΰ¤‹†?ΰ’c‚Ε”m?†ζ“Ύγ‚Μ¤‹†‚π®?¬‚µ‚ά‚µ‚½?B‰p?‘‚ΜƒPƒ“ƒuƒƒbƒW‘εw‚Ε?¶•¨‰»w‚π?κ?U‚µ”m?†‚πζ“Ύ‚µ‚ά‚µ‚½?B—L?”‚Θ‹ΖE?‚Ι•SΘ?γ‚Μ_•¶‚πf?Ϊ‚µ‚Δ‚Ά‚ά‚·?B<P>

Hollings C. Renton - <a href=mailto:hollings@ONYX-pharm.com>hollings@ONYX-pharm.com</a><BR>
1993”N‚ΙONYX‚Ι“όΠ‚·‚ι‘O‚Ι?AHollings Renton ‚Ν?AChiron Corporation‚ΜΠ’·‚¨‚ζ‚Ρ‹Ζ–±’S“–?Σ”C‚π“–±‚µ‚Δ‚Ά‚ά‚µ‚½?B Chiron‚Cetus Corporation‚π”ƒϋ‚µ‚½‚Ι‚»‚Μ?E–±‚Ι?A‚«‚ά‚µ‚½?B‚»‚Μ‘O‚Ν?ACetus Corporation‚Ε1987”N‚©‚η‹Ζ–±’S“–?Σ”C‚π‹Ξ‚ί‚ι‚Ι‘±‚«?A1990”N‚©‚ηΠ’·‚Ι?A”C‚µ‚Δ‚Ά‚ά‚µ‚½?Bƒ~ƒVƒKƒ“?B—§‘εw‚Εo‰cw?Cm?†‚πζ“Ύ‚µ‚Δ‚Ά‚ά‚·?B<P>

Dr. William Gerber - <a href=mailto:bgerber@ONYX-pharm.com>bgerber@ONYX-pharm.com</a><BR>
Dr. Gerber ‚Ν?A1991”N12?ACetus Corporation ”ƒϋ‚Μ‚©‚ηChiron‚Μ?f’f–‹Ζ•”‚ΜΠ’·‚Ε‚µ‚½‚?A‚»‚Μγ?AChiron Corporation ‚©‚ηONYX‚ΙΪ‚θ‚ά‚µ‚½?B 1987”N‚ΙƒR?[ƒ|ƒ?[ƒg?Eƒxƒ“ƒ`ƒƒ?[’S“–‚ΜƒfƒCƒƒNƒ^?[‚Ζ‚µ‚ΔCetus‚Ι“όΠ‚µ?A1988
”N11‚ΙPCR (Polymerase Chain Reaction)–‹Ζ•”‚Μ•›Π’·?E•”’·‚Ι?A”C‚µ‚ά‚µ‚½?BƒJƒƒtƒHƒ‹ƒjƒA?B—§‘εw‚ΜƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR?Eƒ?ƒfƒCƒJƒ‹?EƒZƒ“ƒ^?[‚Ε?A‰Θw?κ?U‚Μwm‚¨‚ζ‚Ργw”m?†‚πζ“Ύ‚µ‚ά‚µ‚½?B<P>

<B>ζ’χ–πυ?F</B><BR>
Sam Colella<BR>
Institutional Venture Partners<BR>
3000 Sand Hill Rd.<BR>
Building 2, Suite 290<BR>
Menlo Park, CA 94025<P>

Brook Byers<BR>
Kleiner Perkins Caufield & Byers<BR>
2750 Sand Hill Road<BR>
Menlo Park, CA 94025<P>

Kevin Kinsella<BR>
Sequana Therapeutics, Inc.<BR>
11099 North Torrey Pines Rd.<BR>
Ste 160<BR>
LaJolla, CA 92037<P>

Walter Moos<BR>
Chemical Therapeutics<BR>
Chiron Corporation<BR>
4560 Horton Street<BR>
Emeryville, CA 94608<P>

Kathleen LaPorte<BR>
Sprout Group<BR>
3000 Sand Hill Rd., 4-270<BR>
Menlo Park, CA 94025-7114<P>

Wolfgang Hartwig, Ph.D.<BR>
Vice President Research<BR>
Bayer Corporation<BR>
400 Morgan Lane<BR>
West Haven, CT 06516-4175<P>

Frank McCormick, Ph.D.<BR>
Chief Scientific Officer<BR>
ONYX Pharmaceuticals<BR>
3031 Research Drive<BR>
Richmond, CA 94806<P>

Hollings Renton<BR>
President and CEO<BR>
ONYX Pharmaceuticals<BR>
3031 Research Drive<BR>
Richmond, CA 94806<P>

<B>‰Θw?κ–εΪ–β?F</B><BR>
Eric Fearon, M.D.<BR>
Division of Molecular Medicine & Genetics<BR>
4301 MSRB 3, Box 0638<BR>
University of Michigan Medical Center<BR>
1150 W. Medical Center Dr.<BR>
Ann Arbor, MI 48109-0638<P>

Henry Bourne, M.D.<BR>
UCSF Department of Pharmacology<BR>
1210 Science Building - Box 0502<BR>
San Francisco, CA 94143<P>

Edward R. Harlow, Jr., Ph.D. (Chairman)<BR>
MGH Cancer Center<BR>
Laboratory of Molecular Oncology<BR>
Building 149-13th Street<BR>
Charlestown, MA 02129<P>

Peter M. Howley, M.D.<BR>
Chairman, Dept. of Pharmacology<BR>
Harvard Medical School<BR>
200 Longwood Avenue, Bldg. D2 Room 630<BR>
Boston, MA 02115<P>


Owen N. Witte, M.D.<BR>
UCLA McDonald Research Lab<BR>
10833 Le Conte Avenue<BR>
Los Angeles, CA 90024-1662<P>

Arnold J. Levine, Ph.D.<BR>
Chairman and Professor<BR>
Department of Molecular Biology<BR>
Lewis Thomas Laboratory<BR>
Princeton University<BR>
Princeton, NJ 08544-1014<P>

Burton Christensen, Ph.D.<BR>
48 Philhower Road<BR>
Lebanon, NJ 08833<P>

Eileen White, Ph.D.<BR>
Center for Advanced Biotechnology and Medicine<BR>
679 Hoes Lane<BR>
Piscataway, NJ 08854<P>

Bruce A.J. Ponder, Ph.D.<BR>
CRC Human Cancer Genetics Group<BR>
Level 3, Laboratories Block, Box 238<BR>
Addenbrooke's Hospital<BR>
Hills Road<BR>
Cambridge, England CB2 2QQ<P>

Dr. Douglas Hanahan<BR>
Hormone Research Institute, Rm. HSW 1090<BR>
UC San Francisco<BR>
School of Medicine<BR>
San Francisco, CA 94121<P>

<A HREF = "http://www.sosei.com/"><IMG  Align=Middle SRC="../Graphics/home_button.gif"></A><A HREF = "http://www.sosei.com/">  ƒz?[ƒ€?Eƒy?[ƒW</A><P>
<HR></BODY>
<ADDRESS><FONT SIZE=3>
Updated October 10, 1995.
Copyright &copy; 1995 <A HREF = "http://www.genweb.com/">GenWeb</A>.
All rights reserved.</FONT></ADDRESS>
<!--  

<P>‚¨–β‚Ά?‡‚ν‚Ή‚Ν?ADr. William Gerber‚ά‚Ε?B
Dr. William Gerber
Chief Operating Officer
ONYX Pharmaceuticals
3031 Research Drive
Richmond, CA  94806
510-262-8772
Fax:  510-222-9758</P>
</HTML>



  -->
</DOC>